Melanotan I (MT-I) is a synthetic linear analog of α-melanocyte-stimulating hormone (α-MSH). In research settings, it is valued for its high selectivity toward the melanocortin-1 receptor (MC1R) and minimal central nervous system activity, making it a preferred tool for cutaneous, pigmentation, photobiology, and immune-signaling studies.

Sequence: Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH₂
Molecular Formula: C₇₈H₁₁₁N₂₁O₁₉
Molecular Weight: 1646.8 g/mol
PubChem CID: 16197727

1. Melanogenesis & Pigmentation Research

Primary application

MT-I is widely used to:

• Selectively activate MC1R on melanocytes

• Elevate intracellular cAMP

• Induce MITF expression

• Increase melanogenic enzyme transcription (TYR, TYRP-1, TYRP-2)

Research uses include:

• Controlled melanin synthesis assays

• Eumelanin vs pheomelanin pathway studies

• Benchmarking melanocyte responsiveness to MC1R agonism

Because of its predictability, MT-I often serves as a reference α-MSH analog in pigmentation experiments.

2. Photobiology & UV-Response Models

In preclinical skin models, Melanotan I is applied to study:

• UV-induced cellular stress pathways

• Melanin-mediated photoprotection mechanisms

• Oxidative stress and reactive oxygen species (ROS) modulation

By favoring eumelanin production, MT-I enables researchers to explore how pigment type influences UV absorption and cellular resilience.

3. MC1R-Selective Receptor Pharmacology

MT-I’s receptor selectivity makes it especially useful in:

• MC1R-specific signaling studies

• Receptor–ligand binding assays

• Structure–activity relationship (SAR) research

This profile allows researchers to isolate peripheral melanocortin signaling without confounding CNS effects.

4. Immunomodulation & Inflammatory Signaling

MC1R is expressed on several immune and skin-resident cells, including:

• Macrophages

• Dendritic cells

• Keratinocytes

In vitro and preclinical studies use MT-I to examine:

• Cytokine expression modulation

• Anti-inflammatory signaling pathways

• Interaction with NF-κB, MAPK, and CREB signaling cascades

These studies focus on mechanistic immune regulation, not therapeutic outcomes.

5. Skin Biology & Barrier Function Research

Melanotan I has been utilized in experimental systems to explore:

• Melanocyte–keratinocyte signaling

• Pigment transfer mechanisms

• Cellular differentiation and survival pathways in skin tissue models

Its MC1R specificity makes it well-suited for localized skin signaling investigations.

6. Peptide Design & Stability Comparisons

As a linear α-MSH analog, MT-I is frequently used as a comparator in:

• Linear vs cyclic peptide stability studies

• Proteolytic degradation assays

• Peptide half-life and receptor residence time evaluations

These comparisons are foundational in peptide engineering and drug-design research.

Key Research Attributes

• ✔ High MC1R selectivity

• ✔ Minimal CNS melanocortin engagement

• ✔ Predictable melanogenesis signaling

• ✔ Widely cited in pigmentation and photobiology literature

• ✔ Useful control compound in melanocortin research

1. Ligand–Receptor Interaction

Melanotan I (MT-I) is a synthetic linear analog of α-melanocyte-stimulating hormone (α-MSH).
In preclinical systems, it acts as a high-selectivity agonist of the melanocortin-1 receptor (MC1R), a Gs-coupled GPCR expressed predominantly on melanocytes and certain immune cells.

• Primary receptor: MC1R

• Minimal activation of: MC3R, MC4R, MC5R

This receptor selectivity defines MT-I’s localized, skin-focused signaling profile.

2. Primary Signal Transduction: Gs → cAMP

Upon MT-I binding to MC1R:

1. Gs protein activation

2. Stimulation of adenylyl cyclase

3. Elevation of intracellular cAMP

4. Activation of protein kinase A (PKA)

This Gs–cAMP–PKA axis is the dominant mechanistic pathway triggered by Melanotan I.

3. Nuclear Transcriptional Activation

Activated PKA phosphorylates CREB (cAMP response element-binding protein), which:

• Increases transcription of MITF (microphthalmia-associated transcription factor)

• MITF functions as the master transcriptional regulator of melanocyte biology

MITF upregulates expression of melanogenic enzymes:

• Tyrosinase (TYR)

• TYRP-1

• TYRP-2

➡ Functional outcome: increased melanogenesis with a bias toward eumelanin synthesis.

4. Melanin Type Modulation

MC1R activation by Melanotan I shifts melanocyte activity:

• Away from pheomelanin (red/yellow pigments)

• Toward eumelanin (brown/black pigments)

Eumelanin has greater:

• UV-absorbing capacity

• Free-radical scavenging ability

This mechanistic shift is a core focus in photobiology and oxidative stress research.

5. Secondary Signaling & Crosstalk

In addition to canonical cAMP signaling, MC1R activation by MT-I has been shown in preclinical models to influence:

• MAPK / ERK pathways (cell survival, differentiation)

• PI3K–Akt signaling (stress response modulation)

• NF-κB inhibition (anti-inflammatory signaling)

These effects are context-dependent and vary by cell type and experimental conditions.

6. Immune & Anti-Inflammatory Signaling

MC1R is also expressed on:

• Macrophages

• Dendritic cells

• Keratinocytes

MT-I–mediated MC1R activation in immune cells has been associated with:

• Reduced pro-inflammatory cytokine expression

• Enhanced anti-inflammatory signaling

• Modulation of innate immune responses

This has made MT-I useful in in-vitro inflammation and immunomodulation studies.

7. Limited Central Nervous System Engagement

Due to:

• Linear peptide structure

• Lower lipophilicity

• Reduced blood–brain barrier penetration

Melanotan I exhibits minimal CNS melanocortin signaling in preclinical research, in contrast to Melanotan II.

This mechanistic distinction:

• Limits MC3R/MC4R activation

• Reduces confounding neuroendocrine effects

• Supports its use in peripheral-only signaling models

Mechanistic Summary (Signal Flow)

Melanotan I → MC1R binding → Gs activation → ↑ cAMP → PKA activation → CREB phosphorylation → ↑ MITF → ↑ melanogenic enzyme transcription → enhanced eumelanin production